Consolidation of Medical Laboratory Services in Hospital Universiti Sains Malaysia through the Establishment of Central Diagnostic Laboratory - Planning, Challenges, and Benefits
Keywords:
Automation, centralisation, diagnostic service, Hospital USMAbstract
Medical laboratory (ML) is the backbone and one of the main components of hospital services. ML provides analytical test results and pathology reports to assist clinicians to treat patients with reliable diagnostic data and evidence for appropriate interventions or therapies. For over three-decade since its establishment, Hospital Universiti Sains Malaysia (HUSM) has grown beyond its foundation. A reimagining of HUSM ML is important to provide a safe and quality experience to patients. This article outlines the history, driving factors, objectives, design and structure, challenges, potential benefits, and steering team of HUSM ML routine tests consolidation into the Central Diagnostic Laboratory (CDL). In summary, CDL is anticipated to enhance HUSM's ML service, research, and teaching using its own sustainable, efficient, and innovative approaches.References
World Health Organization. Hospitals [Internet]. 2021. Available from: https://www.who.int/health-topics/hospitals#tab=tab_1
Kamari Z. Hospital Universiti Sains Malaysia (HUSM): 25 Years of Excellent Service. Malays J Med Sci [Internet]. 2009;16(1):pp16–24. Available from: https://pubmed.ncbi.nlm.nih.gov/22589644/
Nizamuddin WA. Sejarah Penubuhan dan Perkembangannya [Internet]. 2020. p. 1745258. Available from: http://www.hospital.usm.my/index.php/profil-husm/sejarah-penubuhan
Department of Pathology School of Medical Sciences USM Health Campus. Introduction, Department of Pathology [Internet]. Department of Pathology Website. 2020. Available from: https://medic.usm.my/pathology/index.php?option=com_content&view=article&id=926&Itemid=239&lang=en
Department of Chemical Pathology School of Medical Sciences USM Health Campus. Chempath History: Department of Chemical Pathology [Internet]. Department of Chemical Pathology. 2020 [cited 2021 Mar 1]. Available from: https://medic.usm.my/chempath/en/2012-07-03-01-54-50/2012-07-03-03-49-50
Department of Hematology School of Medical Sciences USM Health Campus. Our History, Department of Hematology [Internet]. 2020 [cited 2021 Mar 1]. Available from: https://medic.usm.my/hematology/en/about-us/our-history
Armbruster DA, Overcash DR, Reyes J. Clinical Chemistry Laboratory Automation in the 21st Century - Amat Victory curam (Victory loves careful preparation). Clinical Biochemistry Review. 2014;35(3):pp143–53.
Rin G Da, Zoppelletto M, Lippi G. Integration of Diagnostic Microbiology in a Model of Total Laboratory Automation. Lab Medicine. 2016;47(1):pp73–82.
Archetti C, Montanelli A, Finazzi D, Caimi L, Garrafa E. Clinical laboratory automation: a case study. J Public Health Res [Internet]. 2017;6:pp31–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477477/pdf/jphr-6-1-881.pdf
Church DL, Hall P. Centralization of a regional clinical microbiology service: The Calgary experience. Canadian Journal of Infectious Diseases. 1999;10(6):pp393–402.
Mustafa AZ. Buku Panduan Perkhidmatan Makmal Hematologi, Hospital USM [Internet]. 2021st ed. Mustafa AZ, Hassan R, Yusoff SM, Bahar R, Ramli M, Hassan MN, editors. Kota Bharu, Kelantan: Hospital Universiti Sains Malaysia; 2021. 61 p. Available from: https://medic.usm.my/haematology/services/guidelines-book
Baharuddin KA, Wahab SFA, Rahman NHNA, Mohamad NAN, Kamauzaman THT, Yazid Md Noh A, et al. The Record-Setting Flood of 2014 in Kelantan: Challenges and Recommendations from an Emergency Medicine Perspective and Why the Medical Campus Stood Dry. Malaysian Journal of Medical Sciences. 2015;22(2):pp1–7.
Yahaya NS, Lim C-S, Jamaluddin UA, Pereira JJ. The December 2014 flood in Kelantan : A post-event perspective. Warta Geologi. 2015;41(3):pp54–7.
Hawker CD. Laboratory Automation: Total and Subtotal. Clin Lab Med [Internet]. 2007;27(4):pp749–70. Available from: labmed.theclinics.com
Genzen JR, Burnham CAD, Felder RA, Hawker CD, Lippi G, Peck Palmer OM. Challenges and Opportunities in Implementing Total Laboratory Automation. Clin Chem [Internet]. 2018;64(2):pp259–64. Available from: http://hwmaint.clinchem.aaccjnls.org/cgi/doi/10.1373/clinchem.2017.274068
F. Hoffmann-La Roche Ltd. Cobas® infinity laboratory solution [Internet]. F. Hoffman-La Roche Ltd. 2021 [cited 2021 Mar 1]. Available from: https://diagnostics.roche.com/global/en/products/systems/cobas-infinity-laboratory-solution.html
F. Hoffmann-La Roche Ltd. About Us, Roche Diagnostics [Internet]. 2020 [cited 2021 Mar 1]. Available from: https://diagnostics.roche.com/global/en/products/systems/cobas-infinity-laboratory-solution.html
Roche Diagnostics (Schweiz) AG. cobas® infinity laboratory solution, integration to the next power [Internet]. Roche Diagnostics (Schweiz) AG. 2017 [cited 2022 Oct 26]. p. 7. Available from: https://diagnostics.roche.com/content/dam/diagnostics/Blueprint/en/pdf/sis/cobas infinity laboratory solution brochure.pdf
Abbott Abbott Park Illinois USA. Discover GLP Systems Automation From Abbott [Internet]. Abbott, Abbott Park, Illinois, USA. 2019 [cited 2021 Mar 1]. Available from: https://www.corelaboratory.abbott/int/en/home
Beckman Coulter Inc. DxA 5000 Total Automation System [Internet]. Beckman Coulter, Inc. 2021 [cited 2021 Mar 1]. Available from: https://www.beckmancoulter.com/products/automation/dxa-5000-lab-automation-system#/overview
Siemens Healthcare Sdn. Bhd. Atellica Portfolio of Laboratory Products [Internet]. 2021 [cited 2021 Mar 1]. p. 2021. Available from: https://www.siemens-healthineers.com/en-my/laboratory-diagnostics/atellica-portfolio
McPherson RA. Automation in the Clinical Laboratory. In: Encyclopaedia of Analytical Chemistry [Internet]. American Cancer Society; 2000. Available from: https://novel-coronavirus.onlinelibrary.wiley.com/doi/abs/10.1002/9780470027318.a0504
Streitberg GS, Angel L, Sikaris KA, Bwititi PT. Automation in clinical biochemistry: Core, peripheral, STAT, and specialist laboratories in Australia. J Lab Autom. 2012 Oct 1;17(5):pp387–94.
Lippi G, Da Rin G. Advantages and limitations of total laboratory automation: A personal overview. Clin Chem Lab Med. 2019;57(6):pp802–11.
Schimke I. Quality and timeliness in medical laboratory testing. Anal Bioanal Chem. 2009;393:pp1499–504.
Scharf RE. Hemostasis Laboratory Diagnostics: Characteristics, Communication Issues, and Current Challenges Resulting from Centralization of Laboratory Medicine. Hamostaseologie [Internet]. 2020 Nov 22;40(04):pp403–12. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/a-1249-8767
Robinson A. Rationale for cost-effective laboratory medicine. Clin Microbiol Rev. 1994;7(2):pp185–99.
Trenti T. Synergy between point-of-care testing and laboratory consolidations. The Journal of the International Federation of Clinical Chemistry and Laboratory Medicine. 2021;32(3):pp328–36.
The Web Editorial. The Civilian second best Italian hospital [Internet]. Giornaledi Brescia. 2021 [cited 2022 Dec 5]. p. 1. Available from: https://www.giornaledibrescia.it/brescia-e-hinterland/il-civile-secondo-miglior-ospedale-italiano-1.1777004
Project Management Hut Team. Managing Project Risks [Internet]. 2010 [cited 2021 Mar 7]. Available from: https://pmhut.com/managing-project-risks
American Society of Safety Professionals. Conducting a Risk Assessment [Internet]. 2019 [cited 2021 Mar 7]. Available from: https://www.assp.org/news-and-articles/2019/02/12/conducting-a-risk-assessment
Downloads
Additional Files
Published
Issue
Section
License
JBCS Publication Ethics
JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.
Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.
Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.
This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.
Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.
In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).
Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.
CONFLICT OF INTEREST
Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
HUMAN AND ANIMAL RIGHTS
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
INFORMED CONSENT
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.
DATA SHARING POLICY
JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible
Authors who do not wish to share their data must state that data will not be shared, and give the reason.
COPYRIGHT NOTICE
The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
